Ciprofloxacin in combination with metronidazole

Area of Science:

• Microbiology
• Pharmacology
• Infectious Diseases

Background:

• Ciprofloxacin exhibits reduced activity against anaerobic pathogens.
• Mixed aerobic/anaerobic infections necessitate combination antimicrobial therapy.

Purpose of the Study:

• To evaluate the in vitro efficacy of ciprofloxacin in combination with metronidazole against aerobic and anaerobic pathogens.
• To determine if metronidazole affects ciprofloxacin's activity against common aerobic and anaerobic bacteria.

Main Methods:

• Kill-kinetic curves were utilized to assess bacterial killing over time.
• Ciprofloxacin was tested in combination with various concentrations of metronidazole (2-40 mg/l).
• The study included aerobic pathogens (Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, Enterococcus faecalis) and anaerobic pathogens (Clostridium perfringens, Clostridium difficile).

Main Results:

• High metronidazole concentrations did not impair ciprofloxacin's bactericidal efficacy against aerobic pathogens.
• Ciprofloxacin and metronidazole combination showed no reduced activity against anaerobic pathogens.
• Therapeutically achievable concentrations of metronidazole combined with ciprofloxacin demonstrated slightly enhanced potency against tested clostridia compared to monotherapy.

Conclusions:

• Ciprofloxacin-metronidazole combination therapy is a viable option for treating mixed aerobic/anaerobic infections.
• Metronidazole does not antagonize the activity of ciprofloxacin against the tested aerobic and anaerobic bacteria.
• The combination may offer synergistic or additive benefits for infections involving Clostridium species.